Fairtree Asset Management Pty Ltd Buys 1,221 Shares of HCA Healthcare, Inc. $HCA

Fairtree Asset Management Pty Ltd raised its position in HCA Healthcare, Inc. (NYSE:HCA) by 69.6% during the third quarter, Holdings Channel reports. The firm owned 2,975 shares of the company’s stock after purchasing an additional 1,221 shares during the period. Fairtree Asset Management Pty Ltd’s holdings in HCA Healthcare were worth $1,268,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Norges Bank acquired a new stake in HCA Healthcare during the 2nd quarter worth about $1,152,408,000. Viking Global Investors LP grew its stake in HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Nordea Investment Management AB lifted its stake in HCA Healthcare by 5.2% in the third quarter. Nordea Investment Management AB now owns 975,741 shares of the company’s stock valued at $415,656,000 after buying an additional 47,960 shares during the period. Pacer Advisors Inc. grew its position in shares of HCA Healthcare by 6,115.3% during the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after buying an additional 896,437 shares during the period. Finally, LSV Asset Management boosted its stake in HCA Healthcare by 0.4% during the second quarter. LSV Asset Management now owns 868,849 shares of the company’s stock worth $332,856,000 after acquiring an additional 3,396 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $528.69 on Monday. HCA Healthcare, Inc. has a one year low of $295.00 and a one year high of $552.90. The company has a market cap of $118.23 billion, a P/E ratio of 18.63, a P/E/G ratio of 1.63 and a beta of 1.34. The firm has a 50-day moving average of $493.99 and a 200-day moving average of $460.92.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the business posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is 10.15%.

Wall Street Analysts Forecast Growth

HCA has been the topic of several research reports. Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $452.00 to $481.00 and gave the company an “equal weight” rating in a report on Friday, January 30th. Sanford C. Bernstein set a $541.00 price target on HCA Healthcare in a report on Monday, February 9th. Royal Bank Of Canada upped their target price on HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. JPMorgan Chase & Co. lifted their price target on shares of HCA Healthcare from $420.00 to $535.00 and gave the company a “neutral” rating in a research report on Friday, February 20th. Finally, KeyCorp set a $503.00 price objective on shares of HCA Healthcare in a research note on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $534.50.

Insider Activity at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the firm’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the sale, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president owned 30,003 shares in the company, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 15,214 shares of company stock worth $7,797,595 in the last ninety days. Corporate insiders own 1.30% of the company’s stock.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst upgrade/price-target lift — Mizuho set a new $585 price target for HCA, reinforcing bullish analyst sentiment and helping support the stock’s rally. Read More.
• Positive Sentiment: Post‑earnings momentum — Analysts and writeups (Zacks) highlight HCA’s strong post‑earnings performance (EPS beat and raised FY26 guidance), which is a key reason for recent share gains. Read More.
• Positive Sentiment: Investor roadshow / conference calendar — HCA will present at multiple March healthcare conferences (TD Cowen, Raymond James, Barclays, Leerink, Oppenheimer), increasing institutional visibility and liquidity. Read More.
• Positive Sentiment: Expansion & facility investments — TriStar (an HCA division) is planning a $21M freestanding ER in Fairview and HCA (with Ascension) is targeting high‑growth markets with ER builds, signaling organic growth and franchise expansion. Read More.
• Positive Sentiment: Market strategy: ER build partnership — Coverage on HCA and Ascension targeting growth markets with ER builds points to disciplined capital deployment to capture patient volumes. Read More.
• Positive Sentiment: Quality recognition — A local report highlights high marks for HCA on CABG outcomes, which supports reputation and could help referrals/volume over time. Read More.
• Positive Sentiment: Brand and reputation wins — HCA and several systems made Fortune’s Most‑Admired list, a positive for reputation and hiring/partnerships. Read More.
• Neutral Sentiment: Local market developments — Coverage of Northeast Florida health‑care development (HCA, Baptist, Ascension St. Vincent’s) outlines competitive dynamics; useful for regional growth outlook but not an immediate system‑wide catalyst. Read More.
• Neutral Sentiment: New clinic opening — HCA Florida’s North Florida Hospital launched a test‑and‑treat clinic (local operational expansion), positive for access but a limited impact on consolidated results. Read More.
• Neutral Sentiment: Governance / compensation update — HCA disclosed its 2026 executive bonus plan and a longtime board member will retire; watch for details tying pay to metrics, but this is mostly governance housekeeping. Read More.
• Neutral Sentiment: Comparative performance pieces — A Yahoo Finance comparison of HCA vs. peer healthcare stocks offers context for investors but contains no new company-specific catalyst. Read More.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.